Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial
- Resource Type
- Article
- Authors
- Hui, Ai-Min; Li, Jingxin; Zhu, Li; Tang, Rong; Ye, Huayue; Lin, Mei; Ge, Lei; Wang, Xiyuan; Peng, Fuzhong; Wu, Zhenggang; Guo, Xiling; Shi, Yunfeng; Pan, Hongxing; Zhu, Jiahong; Song, Zhizhou; Qiu, Jingjun; Wang, Wei; Zheng, Jianfei; Ozhelvaci, Orkun; Shpyro, Svetlana; Bushway, Meghan; Derhovanessian, Evelyna; Kühnle, Marie-Cristine; Luxemburger, Ulrich; Muik, Alexander; Shishkova, Yoana; Khondker, Zakaria; Hu, Simin; Lagkadinou, Eleni; Şahin, Uğur; Türeci, Özlem; Zhu, Fengcai
- Source
- In The Lancet Regional Health - Western Pacific December 2022 29
- Subject
- Language
- ISSN
- 2666-6065